Associated Papers
Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk.
Santiago JL et al.
Frontiers in Immunology, 2021
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
Wagner M et al.
Journal of Neuroimmunology, 2015
Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.
Prescott NJ et al.
Plos Genetics, 2015
25671699 (PubMed )
Supplement: pgen.1004955.s006.xlsx › SNVs
CD80 and CD86 polymorphisms in populations of various ancestries: 5 new CD80 promoter alleles.
Beltrame MH et al.
Human Immunology, 2012
PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis.
Ishizaki Y et al.
Human Genetics, 2010
A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis.
Abdallah AM et al.
International Journal of Immunogenetics, 2006
Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.
Teutsch SM et al.
Journal of Neuroimmunology, 2004
CD86 gene polymorphisms: no association with Type I diabetes among Finnish subjects.
Turpeinen H et al.
Diabetologia, 2002
New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus.
Matsushita M et al.
Genes and Immunity, 2000
Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis.
Handa T et al.
Respiration; International Review of Thoracic Diseases, 0
Pemphigus vulgaris and pemphigus foliaceus determined by CD86 and CTLA4 polymorphisms.
Tanasilovic S et al.
Clinics in Dermatology, 0
Select a paper to view details